1-3 of 3
Todd R. Lenvik
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

PD-1 Is Expressed at Low Levels on All Peripheral Blood Natural Killer Cells but Is a Significant Suppressor of NK Function Against PD-1 Ligand Expressing Tumor Targets

Zachary Davis, PhD BS, Martin Felices, PhD, Todd R Lenvik, Sujan Badal, Peter Hinderlie, Bruce R. Blazar, MD, Daniel A. Vallera, PhD, Jeffrey S. Miller, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 621.
https://doi.org/10.1182/blood-2019-127261
Published: 2019
Journal Articles

Second-Generation Camelid Trike Induces Improved NK Cell Mediated Targeting of AML in Pre-Clinical Models

Martin Felices, PhD, Craig E. Eckfeldt, MD PhD, Todd R Lenvik, Behiye Kodal, Alexander J. Lenvik, Laura Bendzick, Caitlin Ryan, Melissa A. Geller, Sarah Cooley, MD, Daniel J. Weisdorf, MD, Daniel A. Vallera, PhD, Jeffrey S. Miller, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4465.
https://doi.org/10.1182/blood.V130.Suppl_1.4465.4465
Published: 2017
Journal Articles

Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9

Michelle K. Gleason, Todd R. Lenvik, Valarie McCullar, Martin Felices, M. Shea O'Brien, Sarah A. Cooley, Michael R. Verneris, Frank Cichocki, Carol J. Holman, Angela Panoskaltsis-Mortari, Toshiro Niki, Mitsuomi Hirashima, Bruce R. Blazar, Jeffrey S. Miller
Journal: Blood
Blood (2012) 119 (13): 3064–3072.
https://doi.org/10.1182/blood-2011-06-360321
Published: 2012
Includes: Supplemental data